Algorae Pharmaceuticals Limited has released a press release.
AlgoraeOS Artificial Intelligence Platform Launched
Filed with ASX ·
6ix hasn’t read this filing yet.
Algorae Pharmaceuticals Limited on 6ix
Earlier from Algorae Pharmaceuticals
- Positive results from AI-116 in vitro studies
- Artificial Intelligence Platform Update
- Response to ASX Price Query
- NTCELL Project Update
- Quarterly Activities Report/Appendix 4C Cash Flow Statement
Later from Algorae Pharmaceuticals
- 24 New AI-Generated Drug Targets
- Significant Cardioprotection Qualities in AI-168 Studies
- Half Yearly Report Announcement and Appendix 4D
- Algorae Receives A$451,359 R&D Cash Rebate from ATO
- Peter Mac Partners with Algorae on AI Drug Targets
Follow Algorae Pharmaceuticals into a list and get an email when it puts out news.
Follow Algorae Pharmaceuticals